# LeenLife Pharma International Inc. — Form D

LeenLife Pharma International Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-20. The offering totals $124K, of which $124K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-12-20
- Form: D
- Accession: 0001725612-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $124K
- Amount sold: $124K
- Investors: 4
- Date of first sale: 2017-12-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-301202

## Issuer

- Name: LeenLife Pharma International Inc.
- CIK: 0001725612
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2014
- Address: SUITE 380-580 HORNBY STREET, VANCOUVER, A1, V6C3B6
- Phone: 778-688-1799

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Marcin Lukaszewcz | Director | Vancouver, A1 |
| Casey Forward | Executive Officer | Vancouver, A1 |
| Marcin Lukaszewcz | Executive Officer | Vancouver, A1 |

## More

- [CIK 1725612 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1725612&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001725612-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.